Pharmaceutical Technology Europe
The emerging markets represent an attractive investment opportunity for the pharmaceutical industry because of the countries' growing economies and unmet medical needs.
Sandy Macrae
Advertisement
Sandy Macrae is Senior Vice President APJEM R&D, world-wide business development, GlaxoSmithKline (USA). Tel. +1 610 270 5659 [email protected]
Articles by Sandy Macrae
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA Duloxetine Recall Highlights Generic Manufacturing Quality Gaps
2
Germany Pharma Tariff Threat: What Manufacturers Need to Know
3
Why Pharma Dealmaking Slowed in Q1 2026 and What Is Coming Next
4
PharmTech Weekly Roundup—June 19, 2026
5